Prolonged use of aspirin, an NSAID that inhibits cyclooxygenase 1 (COX1) and COX2 and thus decreases inflammation, was recently reported to significantly reduce the incidence of cancer mainly in colorectal cancer and in other malignancies, including BC [91,92]. This evidence concerns the gene PTGS1 and breast cancer.